Immunologically High-Risk Penetrating Keratoplasty

[1]  Z. Haskova,et al.  Local Treatment With Alpha-Melanocyte Stimulating Hormone Reduces Corneal Allorejection , 2009, Transplantation.

[2]  R. Dana,et al.  Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study. , 2009, Archives of ophthalmology.

[3]  Chung-Tien Lin,et al.  Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis. , 2009, Investigative ophthalmology & visual science.

[4]  R. Dana,et al.  ‘Chimeric’ Grafts Assembled from Multiple Allodisparate Donors Enjoy Enhanced Transplant Survival , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  W. Tucker,et al.  Bevacizumab (Avastin) for Corneal Neovascularization-Corneal Light Shield Soaked Application , 2009, Cornea.

[6]  B. Seitz,et al.  Mycophenolate mofetil (MMF) following penetrating high-risk keratoplasty: long-term results of a prospective, randomised, multicentre study , 2009, Eye.

[7]  R. Dana,et al.  Differential Roles of Direct and Indirect Allorecognition Pathways in the Rejection of Skin and Corneal Transplants , 2009, Transplantation.

[8]  R. Dana,et al.  Levels of Foxp3 in Regulatory T Cells Reflect Their Functional Status in Transplantation1 , 2009, The Journal of Immunology.

[9]  G. Gerten.  Bevacizumab (Avastin) and Argon Laser to Treat Neovascularization in Corneal Transplant Surgery , 2008, Cornea.

[10]  A. Khodadoust.  The Allograft Rejection Reaction: The Leading Cause of Late Failure of Clinical Corneal Grafts , 2008 .

[11]  S. Kaufman,et al.  Long-term Use of Topical Tacrolimus (FK506) in High-risk Penetrating Keratoplasty , 2008, Cornea.

[12]  Qizhi Tang,et al.  The Foxp3+ regulatory T cell: a jack of all trades, master of regulation , 2008, Nature Immunology.

[13]  I. Bahar,et al.  Subconjunctival Bevacizumab Injection for Corneal Neovascularization , 2008, Cornea.

[14]  K. Maruyama,et al.  Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation. , 2008, Archives of ophthalmology.

[15]  J. Schwartzkopff,et al.  [Basiliximab following penetrating risk-keratoplasty--a prospective randomized pilot study]. , 2008, Klinische Monatsblatter fur Augenheilkunde.

[16]  M. Dana,et al.  Graft failure IV. Immunologic mechanisms of corneal transplant rejection , 2008, International Ophthalmology.

[17]  D. Coster,et al.  The Immunobiology of Corneal Transplantation , 2007, Transplantation.

[18]  G. Freeman,et al.  The Function of Donor versus Recipient Programmed Death-Ligand 1 in Corneal Allograft Survival1 , 2007, The Journal of Immunology.

[19]  R. Belfort,et al.  The effects of the subconjunctival injection of bevacizumab (Avastin) on angiogenesis in the rat cornea. , 2007, Anais da Academia Brasileira de Ciencias.

[20]  M. Dana,et al.  Effect of the ocular microenvironment in regulating corneal dendritic cell maturation. , 2007, Archives of ophthalmology.

[21]  Björn Bachmann,et al.  Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. , 2007, Investigative ophthalmology & visual science.

[22]  Terry Kim,et al.  Topical bevacizumab therapy for corneal neovascularization. , 2007, Archives of ophthalmology.

[23]  M. Erdurmuş,et al.  Subconjunctival bevacizumab for corneal neovascularization , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[24]  M. Dana,et al.  Deletion of the chemokine receptor CCR1 prolongs corneal allograft survival. , 2007, Investigative ophthalmology & visual science.

[25]  R. Dana,et al.  Corneal antigen-presenting cells. , 2007, Chemical immunology and allergy.

[26]  R. Dana.  Comparison of topical interleukin-1 vs tumor necrosis factor-alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization, and transplant survival (an American Ophthalmological Society thesis). , 2007, Transactions of the American Ophthalmological Society.

[27]  T. Reinhard,et al.  Matching von Minor-Transplantationsantigenen in der perforierenden Keratoplastik , 2007, Der Ophthalmologe.

[28]  P. Chévez-Barrios,et al.  Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin) , 2006, British Journal of Ophthalmology.

[29]  S. Böhringer,et al.  Matching of the Minor Histocompatibility Antigen HLA-A1/H-Y May Improve Prognosis in Corneal Transplantation , 2006, Transplantation.

[30]  V. Shanmuganathan,et al.  Tacrolimus immunosuppression in high-risk corneal grafts , 2006, British Journal of Ophthalmology.

[31]  D. Larkin,et al.  Differential effects of costimulatory pathway modulation on corneal allograft survival. , 2006, Investigative ophthalmology & visual science.

[32]  E. Mayhew,et al.  CD4+ T-Cell–Independent Rejection of Corneal Allografts , 2006, Transplantation.

[33]  D. Böhringer,et al.  An Open Prospective Pilot Study on the Use of Rapamycin after Penetrating High-Risk Keratoplasty , 2006, Transplantation.

[34]  N. Ardjomand,et al.  AB0-Blutgruppenexpression in Hornhäuten mit Transplantatversagen , 2005, Der Ophthalmologe.

[35]  J. Forrester,et al.  Susceptibility of corneal allografts and xenografts to antibody-mediated rejection. , 2005, Immunology letters.

[36]  M. Dana,et al.  Early ocular chemokine gene expression and leukocyte infiltration after high-risk corneal transplantation. , 2005, Molecular vision.

[37]  B. Seitz,et al.  Systemic mycophenolate mofetil avoids immune reactions in penetrating high‐risk keratoplasty: preliminary results of an ongoing prospectively randomized multicentre study * , 2005, Transplant international : official journal of the European Society for Organ Transplantation.

[38]  D. Böhringer,et al.  Immunosuppression with Cyclosporine A and Mycophenolate Mofetil After Penetrating High-Risk Keratoplasty: A Retrospective Study , 2005, Transplantation.

[39]  M. Thiel,et al.  Local or short‐term systemic costimulatory molecule blockade prolongs rat corneal allograft survival , 2005, Clinical & experimental ophthalmology.

[40]  T. Reinhard,et al.  Topical FK506 as immunoprophylaxis after allogeneic penetrating normal‐risk keratoplasty: a randomized clinical pilot study , 2005, Transplant international : official journal of the European Society for Organ Transplantation.

[41]  E. Mayhew,et al.  CD4+ T-Cell–Mediated Mechanisms of Corneal Allograft Rejection: Role of Fas-Induced Apoptosis , 2005, Transplantation.

[42]  M. Dana,et al.  Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity , 2004, Nature Medicine.

[43]  J. Forrester,et al.  Lymph node removal enhances corneal graft survival in mice at high risk of rejection , 2004, BMC ophthalmology.

[44]  P. Wernet,et al.  Improvement of graft prognosis in penetrating normal-risk keratoplasty by HLA class I and II matching , 2004, Eye.

[45]  F. Claas,et al.  Beneficial effect of matching at the HLA-A and -B amino-acid triplet level on rejection-free clear graft survival in penetrating keratoplasty1 , 2004, Transplantation.

[46]  T. Pohl,et al.  Inhibition of corneal allograft reaction by CTLA4-Ig , 1997, Graefe's Archive for Clinical and Experimental Ophthalmology.

[47]  H. Völker‐Dieben.  The effect of immunological and non-immunological factors on corneal graft survival: A single centre study , 1984, Documenta Ophthalmologica.

[48]  P. Moreau,et al.  Expression of HLA-G in human cornea, an immune-privileged tissue. , 2003, Human immunology.

[49]  I. Doxiadis,et al.  Long-Term Outcome in High-Risk Corneal Transplantation and the Influence of HLA-A and HLA-B Matching , 2003, Cornea.

[50]  J. T. Stout,et al.  Corneal transduction to inhibit angiogenesis and graft failure. , 2003, Investigative ophthalmology & visual science.

[51]  M. Thiel,et al.  The potential of antibody‐based immunosuppressive agents for corneal transplantation , 2003, Immunology and cell biology.

[52]  E. Cohen,et al.  Topical Cyclosporine in Pediatric Keratoplasty , 2003, Eye & contact lens.

[53]  M. Dana,et al.  The corneal stroma is endowed with a significant number of resident dendritic cells. , 2003, Investigative ophthalmology & visual science.

[54]  D. Böhringer,et al.  Individual analysis of expected time on the waiting list for HLA-matched corneal grafts. , 2003, Developments in ophthalmology.

[55]  J. Streilein,et al.  The role of minor histocompatibility alloantigens in penetrating keratoplasty. , 2003, Developments in ophthalmology.

[56]  H. Völker‐Dieben,et al.  Histocompatibility and corneal transplantation. , 2003, Developments in ophthalmology.

[57]  P. Hamrah,et al.  Resident Corneal Dendritic Cells That Migrate From Corneal Explants May Mediate Alloreactivity , 2002 .

[58]  M. Dana,et al.  Mechanisms of immunotherapeutic intervention by anti-CD154 (CD40L) antibody in high-risk corneal transplantation. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[59]  Minhua H. Wang,et al.  Studies on the effects of the immunosuppressant FK-506 on the high-risk corneal graft rejection. , 2002, Yan ke xue bao = Eye science.

[60]  U. Rehany,et al.  The conundrum of death, dying and organ donation , 2002, The British journal of ophthalmology.

[61]  M. Dana,et al.  Effect of Locally Administered Anti-CD154 (CD40 Ligand) Monoclonal Antibody on Survival of Allogeneic Corneal Transplants , 2002, Cornea.

[62]  S. Skurkovich,et al.  Treatment of corneal transplant rejection in humans with anti-interferon-γ antibodies , 2002 .

[63]  W. Feuer,et al.  Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency. , 2002, Ophthalmology.

[64]  M. Dana,et al.  Draining Lymph Nodes Play an Essential Role in Alloimmunity Generated in Response to High-Risk Corneal Transplantation , 2002, Cornea.

[65]  D. Lam,et al.  Combined intravenous pulse methylprednisolone and oral cyclosporine A in the treatment of corneal graft rejection: 5-year experience , 2002, Eye.

[66]  J. Jonas,et al.  Immunologic graft reactions after allogenic penetrating keratoplasty. , 2002, American journal of ophthalmology.

[67]  J. Niederkorn,et al.  Effect of alloantibodies on corneal allograft survival. , 2002, Investigative ophthalmology & visual science.

[68]  M. Dana,et al.  Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells. , 2002, Investigative ophthalmology & visual science.

[69]  J. Forrester,et al.  THE IMMUNE RESPONSE TO CORNEAL ALLOGRAFT REQUIRES A SITE-SPECIFIC DRAINING LYMPH NODE1 , 2002, Transplantation.

[70]  R. Dana,et al.  Draining Lymph Nodes of Corneal Transplant Hosts Exhibit Evidence for Donor Major Histocompatibility Complex (MHC) Class II–positive Dendritic Cells Derived from MHC Class II–negative Grafts , 2002, The Journal of experimental medicine.

[71]  Mark D. Aupperlee,et al.  Identification of androgen receptors in rabbit lacrimal gland by immunohistochemsitry. , 2000, Advances in experimental medicine and biology.

[72]  W. Behrens-Baumann,et al.  [Immune suppression by combination therapy with basiliximab and cyclosporin in high risk keratoplasty. A pilot study]. , 2002, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[73]  M. Dana,et al.  Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in the conjunctiva--a potential link between lymphangiogenesis and leukocyte trafficking on the ocular surface. , 2002, Advances in experimental medicine and biology.

[74]  D. Gartry,et al.  Systemic cyclosporin A in high risk penetrating keratoplasties: a case-control study , 2001, The British journal of ophthalmology.

[75]  H. Dua,et al.  Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts. , 2001, Ophthalmology.

[76]  E. Godehardt,et al.  Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients: 3 years' results of a randomized prospective clinical trial , 2001, Graefe's Archive for Clinical and Experimental Ophthalmology.

[77]  R. Dana,et al.  The critical role of lymph nodes in corneal alloimmunization and graft rejection. , 2001, Investigative ophthalmology & visual science.

[78]  M. Dana,et al.  Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants. , 2001, Investigative ophthalmology & visual science.

[79]  J. Naor,et al.  Corneal Graft Outcome Study , 2001, Cornea.

[80]  U. Rehany,et al.  The profile of repeated corneal transplantation. , 2001, Ophthalmology.

[81]  H. Fujishima,et al.  Immunologic Rejection of the Central Graft After Limbal Allograft Transplantation Combined with Penetrating Keratoplasty , 2001, Cornea.

[82]  J. Streilein,et al.  Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice. , 2001, Investigative ophthalmology & visual science.

[83]  B. Ksander,et al.  Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice. , 2001, Investigative ophthalmology & visual science.

[84]  S. Lightman,et al.  Use of cyclosporin in the treatment of steroid resistant post-keratoplasty atopic sclerokeratitis , 2001, The British journal of ophthalmology.

[85]  M. Araie,et al.  Long-term outcome of systemic cyclosporine treatment following penetrating keratoplasty. , 1999, Japanese journal of ophthalmology.

[86]  M. Dana,et al.  Topical soluble tumor necrosis factor receptor type I suppresses ocular chemokine gene expression and rejection of allogeneic corneal transplants. , 2000, Archives of ophthalmology.

[87]  D. Larkin,et al.  Cytokine and chemokine expression kinetics after corneal transplantation. , 2000, Transplantation.

[88]  J. Niederkorn,et al.  The role of cytotoxic T lymphocytes in corneal allograft rejection. , 2000, Investigative ophthalmology & visual science.

[89]  M. Dana,et al.  Twenty-five–Year Panorama of Corneal Immunology: Emerging Concepts in the Immunopathogenesis of Microbial Keratitis, Peripheral Ulcerative Keratitis, and Corneal Transplant Rejection , 2000, Cornea.

[90]  B. Wittig,et al.  Ballistic transfer of minimalistic immunologically defined expression constructs for IL4 and CTLA4 into the corneal epithelium in mice after orthotopic corneal allograft transplantation , 2000, Graefe's Archive for Clinical and Experimental Ophthalmology.

[91]  B. Ksander,et al.  Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition. , 2000, Investigative ophthalmology & visual science.

[92]  M. Isobe,et al.  Characterization of cytokine profiles in corneal allograft with anti-adhesion therapy. , 2000, Transplantation.

[93]  T. Reinhard,et al.  Penetrating keratoplasty in patients with atopic dermatitis with and without systemic cyclosporin A. , 1999, Cornea.

[94]  Santa Jeremy Ono,et al.  Differential chemokine gene expression in corneal transplant rejection. , 1999, Investigative ophthalmology & visual science.

[95]  T. Tsuru,et al.  Increase in orthotopic murine corneal transplantation rejection rate with anterior synechiae. , 1999, Investigative ophthalmology & visual science.

[96]  J. Streilein.  Immunobiology and immunopathology of corneal transplantation. , 1999, Chemical immunology.

[97]  M. Dana,et al.  Early expression of proinflammatory cytokines interleukin-1 and tumor necrosis factor-alpha after corneal transplantation. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[98]  M. Dana,et al.  Expression of cell adhesion molecules on limbal and neovascular endothelium in corneal inflammatory neovascularization. , 1999, Investigative ophthalmology & visual science.

[99]  B. Gebhardt,et al.  Protection of corneal allografts by CTLA4-Ig. , 1999, Cornea.

[100]  M. Dana,et al.  TNF-alpha regulates corneal Langerhans cell migration. , 1999, Journal of immunology.

[101]  H. Endo,et al.  Suppression of allograft rejection with anti-αβ T cell receptor antibody in rat corneal transplantation , 1999 .

[102]  M. Dana,et al.  Corneal transplantation in antibody-deficient hosts. , 1999, Investigative ophthalmology & visual science.

[103]  H. Suzuki,et al.  Effect of a topically applied neutralizing antibody against vascular endothelial growth factor on corneal allograft rejection of rat. , 1998, Transplantation.

[104]  H. Endo,et al.  Cytokine profiles of aqueous humor and graft in orthotopic mouse corneal transplantation. , 1998, Transplantation.

[105]  D. Hodge,et al.  Ten-year postoperative results of penetrating keratoplasty. , 1998, Ophthalmology.

[106]  V. Kuchroo,et al.  CD28/B7 costimulation: a review. , 1998, Critical reviews in immunology.

[107]  M. Dana,et al.  Interleukin-1 Receptor Antagonist Suppresses Langerhans Cell Activity and Promotes Ocular Immune Privilege , 1997 .

[108]  J. Niederkorn,et al.  Oral immunisation as a strategy for enhancing corneal allograft survival , 1997, The British journal of ophthalmology.

[109]  M. Isobe,et al.  Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice. , 1997, Experimental eye research.

[110]  P. Creemers,et al.  An adverse matching effect for the HLA-B locus in corneal transplantation , 1997, Transplant international : official journal of the European Society for Organ Transplantation.

[111]  N. Ehlers,et al.  Significant effect of high-resolution HLA-DRB1 matching in high-risk corneal transplantation. , 1996, Transplantation.

[112]  M. Dana,et al.  Loss and restoration of immune privilege in eyes with corneal neovascularization. , 1996, Investigative ophthalmology & visual science.

[113]  R. Flavell,et al.  The Role of CD40 Ligand in Costimulation and T‐Cell Activation , 1996, Immunological reviews.

[114]  M. Isobe,et al.  Effect of monoclonal antibody to VLA-4 on corneal allograft survival in mice. , 1996, Transplantation proceedings.

[115]  J. Niederkorn,et al.  The effect of oral immunization on corneal allograft survival. , 1996, Transplantation.

[116]  B. Ksander,et al.  Minor H, rather than MHC, alloantigens offer the greater barrier to successful orthotopic corneal transplantation in mice. , 1996, Transplant immunology.

[117]  J. Streilein,et al.  Immunosuppressive properties of tissues obtained from eyes with experimentally manipulated corneas. , 1996, Investigative ophthalmology & visual science.

[118]  S. Gore,et al.  HLA‐DR MATCHING IN CORNEAL TRANSPLANTATION: SYSTEMATIC REVIEW OF PUBLISHED EVIDENCE , 1995, Transplantation.

[119]  S. Gore,et al.  Negative effect of HLA-DR matching on corneal transplant rejection. , 1995, Transplantation proceedings.

[120]  I. Hutchinson,et al.  The humoral response to an allograft , 1995, Eye.

[121]  J. Streilein,et al.  Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye , 1995, Eye.

[122]  U. Pleyer,et al.  Effect of topically applied anti-CD4 monoclonal antibodies on orthotopic corneal allografts in a rat model. , 1995, Investigative ophthalmology & visual science.

[123]  A. Joplin,et al.  Rapamycin inhibits corneal allograft rejection and neovascularization. , 1994, Archives of ophthalmology.

[124]  R. D. Stulting,et al.  Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group. , 1994, Ophthalmology.

[125]  N. Barney,et al.  A Prospective Randomized Trial of Oral Acyclovir After Penetrating Keratoplasty for Herpes Simplex Keratitis , 1994, Cornea.

[126]  W. Paul,et al.  Lymphocyte responses and cytokines , 1994, Cell.

[127]  H. D. Cavanagh,et al.  The high-risk keratoplasty patient--quo vadis? , 1994, Cornea.

[128]  J. Hill,et al.  Systemic cyclosporine in high-risk keratoplasty. Short- versus long-term therapy. , 1994, Ophthalmology.

[129]  R. Nussenblatt,et al.  Expression of Cell Adhesion Molecules in Corneal Graft Failure , 1993, Cornea.

[130]  J. Sugar,et al.  Topical Cyclosporin A in the Treatment of Anterior Segment Inflammatory Disease , 1993, Cornea.

[131]  T. Reinhard,et al.  Perforierende Keratoplastik bei endogenem Ekzem - Eine Indikation für systemisches Ciclosporin A - eine retrospektive Studie über 18 Patienten , 1992 .

[132]  D. Roder,et al.  Factors predictive of corneal graft survival. Report from the Australian Corneal Graft Registry. , 1992, Ophthalmology.

[133]  J. Niederkorn,et al.  Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody. , 1991, Investigative ophthalmology & visual science.

[134]  P. Laughrea,et al.  Association between corneal allograft reactions and HLA compatibility. , 1990, Ophthalmology.

[135]  E. Cohen,et al.  Indications for and outcomes of repeat penetrating keratoplasty. , 1990, American journal of ophthalmology.

[136]  S. Wilson,et al.  Graft failure after penetrating keratoplasty. , 1990, Survey of ophthalmology.

[137]  S. Greenstein,et al.  Trichiasis is a trigger for recurrent corneal graft rejection. , 1990, Cornea.

[138]  M. Belin,et al.  Topical cyclosporine in high-risk corneal transplants. , 1989, Ophthalmology.

[139]  P. Laughrea,et al.  Effect of factors unrelated to tissue matching on corneal transplant endothelial rejection. , 1989, American journal of ophthalmology.

[140]  G. Ippoliti,et al.  Usefulness of CD3 or CD6 anti-T monoclonal antibodies in the treatment of acute corneal graft rejection. , 1989, Transplantation proceedings.

[141]  R. D. Stulting,et al.  Effect of donor epithelium on corneal transplant survival. , 1988, Ophthalmology.

[142]  D. Musch,et al.  Assessment of success and complications of triple procedure surgery. , 1987, American journal of ophthalmology.

[143]  R. D. Stulting,et al.  Penetrating keratoplasty for herpes simplex keratitis and keratoconus. Allograft rejection and survival. , 1987, Ophthalmology.

[144]  Y. Pouliquen,et al.  [Cyclosporin A eyedrops in the prevention of high-risk corneal graft rejection. II. Postoperative clinical results]. , 1987, Journal francais d'ophtalmologie.

[145]  R. D. Stulting,et al.  Corneal neovascularization. Pathogenesis and inhibition. , 1987, Cornea.

[146]  W. Vaughn,et al.  Reduced graft rejection with good HLA-A and B matching in high-risk corneal transplantation. , 1986, The New England journal of medicine.

[147]  J. Pepose,et al.  Detection of HLA class I and II antigens in rejected human corneal allografts. , 1985, Ophthalmology.

[148]  G. Foulks,et al.  Expression of ABO Blood Group, Hematopoietic, and Other Cell‐Specific Antigens by Cells in the Human Cornea , 1985, Cornea.

[149]  R. D. Stulting,et al.  Penetrating keratoplasty in children. , 1984, Ophthalmology.

[150]  H. Taylor,et al.  Transplantation antigens and keratoplasty. , 1983, Australian journal of ophthalmology.

[151]  D. Dawson,et al.  Histocompatibility testing for keratoplasty in high-risk patients. , 1983, Ophthalmology.

[152]  K. Lafferty,et al.  Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. , 1983, Annual review of immunology.

[153]  G. Foulks,et al.  Beneficial effects of histocompatibility in high-risk corneal transplantation. , 1982, American journal of ophthalmology.

[154]  H. Völker‐Dieben,et al.  THE EFFECT OF PROSPECTIVE HLA‐A AND ‐B MATCHING ON CORNEAL GRAFT SURVIVAL , 1982, Acta ophthalmologica.

[155]  J. Krachmer,et al.  Clinical types of corneal transplant rejection. Their manifestations, frequency, preoperative correlates, and treatment. , 1981, Archives of ophthalmology.

[156]  D. Coster.  Factors affecting the outcome of corneal transplantation. , 1981, Annals of the Royal College of Surgeons of England.

[157]  R. Poirier,et al.  Corneal allograft reaction and its relationship to suture site neovascularization. , 1977, Ophthalmic surgery.

[158]  M. Fine,et al.  Penetrating keratoplasty in herpes simplex keratitis. Recurrence in grafts. , 1977, Archives of ophthalmology.

[159]  N. Ehlers,et al.  Corneatransplantation and matching for HLA-A and B. , 1977, Scandinavian journal of urology and nephrology. Supplementum.

[160]  J. R. Batchelor,et al.  HLA MATCHING AND CORNEAL GRAFTING , 1976, The Lancet.

[161]  S. I. Brown,et al.  The significance of anterior synechiae after corneal transplantation. , 1972, American journal of ophthalmology.

[162]  F. Polack.  Scanning electron microscopy of corneal graft rejection: epithelial rejection, endothelial rejection, and formation of posterior graft membranes. , 1972, Investigative ophthalmology.

[163]  A. Silverstein,et al.  The survival and rejection of epithelium in experimental corneal transplants. , 1969, Investigative ophthalmology.